The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines
Abstract
The development of cell culture systems for virus propagation has led to major advances in virus vaccine development. Primary and diploid cell culture systems are now being replaced by the use of continuous cell lines (CCLs). These substrates are gaining increasing acceptance from regulatory authorities as improved screening technologies remove fears regarding their potential oncogenic properties. The Vero cell line is the most widely accepted CCL by regulatory authorities and has been used for over 30 years for the production of polio and rabies virus vaccines. The recent licensure of a Vero cell-derived live virus vaccine (ACAM2000, smallpox vaccine) has coincided with an explosion in the development of a range of new viral vaccines, ranging from live-attenuated pediatric vaccines against rotavirus infections to inactivated whole-virus vaccines against H5N1 pandemic influenza. These developments have illustrated the value of this cell culture platform in the rapid development of vaccines against a range of virus diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
Dengue and Dengue Hemorrhagic Fever
Gubler, D. J. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.480 · Cited by 4,310
Coronavirus as a possible cause of severe acute respiratory syndrome
Peiris, J., Lai, S., Poon, L., Guan, Y., Yam, L., Lim, W., Nicholls, J., Yee, W., Yan, W., Cheung, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13077-2 · Cited by 2,915
Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis
Ruiz-Palacios, G. M., Pérez-Schael, I., Velázquez, F. R., Abate, H., Breuer, T., Clemens, S. C., Cheuvart, B., Espinoza, F., Gillard, P., Innis, B. L., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052434 · Cited by 1,799
Mackenzie, J. S., Gubler, D. J., & Petersen, L. R. (2004) · Nature Medicine · doi:10.1038/nm1144 · Cited by 1,314
Genome Microevolution of Chikungunya Viruses Causing the Indian Ocean Outbreak
Schuffenecker, I., Iteman, I., Michault, A., Murri, S., Frangeul, L., Vaney, M.-C., Lavenir, R., Pardigon, N., Reynes, J.-M., Pettinelli, F., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030263 · Cited by 1,222
Campbell, G. L., Marfin, A. A., Lanciotti, R. S., & Gubler, D. J. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00368-7 · Cited by 792
Enders, J. F., Weller, T. H., & Robbins, F. C. (1949) · Science · doi:10.1126/science.109.2822.85 · Cited by 749
Desmyter, J., Melnick, J. L., & Rawls, W. E. (1968) · Journal of Virology · doi:10.1128/jvi.2.10.955-961.1968 · Cited by 502
A transgenic mouse model for monitoring endoplasmic reticulum stress
Iwawaki, T., Akai, R., Kohno, K., & Miura, M. (2004) · Nature Medicine · doi:10.1038/nm970 · Cited by 471
Rotavirus Vaccines: an Overview
Dennehy, P. H. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-07 · Cited by 399
Evidence for host-cell selection of influenza virus antigenic variants
Schild, G. C., Oxford, J. S., de Jong, J. C., & Webster, R. G. (1983) · Nature · doi:10.1038/303706a0 · Cited by 314
Durbin, A. P., Karron, R. A., Sun, W., Vaughn, D. W., Reynolds, M. J., Perreault, J. R., Thumar, B., Men, R., Lai, C. J., Elkins, W. R., et al. (2001) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.2001.65.405 · Cited by 287
Guirakhoo, F., Pugachev, K., Zhang, Z., Myers, G., Levenbook, I., Draper, K., Lang, J., Ocran, S., Mitchell, F., Parsons, M., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4761-4775.2004 · Cited by 253
Subbarao, K., Chen, H., Swayne, D., Mingay, L., Fodor, E., Brownlee, G., Xu, X., Lu, X., Katz, J., Cox, N., et al. (2003) · Virology · doi:10.1006/viro.2002.1742 · Cited by 246
West Nile Virus Isolation from Equines in Argentina, 2006
Morales, M., Barrandeguy, M., Fabbri, C., Garcia, J., Vissani, A., Trono, K., Gutierrez, G., Pigretti, S., Menchaca, H., Garrido, N., et al. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1210.060852 · Cited by 234
A live, attenuated recombinant West Nile virus vaccine
Monath, T. P., Liu, J., Kanesa-Thasan, N., Myers, G. A., Nichols, R., Deary, A., McCarthy, K., Johnson, C., Ermak, T., Shin, S., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601932103 · Cited by 231
A short history of vaccination
Plotkin, S. L., & Plotkin, S. A. (2013) · Vaccines · doi:10.1016/b978-1-4557-0090-5.00017-3 · Cited by 222
Development of a mammalian cell (Vero) derived candidate influenza virus vaccine
KISTNER, O. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00301-0 · Cited by 221
Self-citationRobertson, J. S., Bootman, J. S., Newman, R., Oxford, J. S., Daniels, R. S., Webster, R. G., & Schild, G. C. (1987) · Virology · doi:10.1016/0042-6822(87)90040-7 · Cited by 218
Monath, T. P., Guirakhoo, F., Nichols, R., Yoksan, S., Schrader, R., Murphy, C., Blum, P., Woodward, S., McCarthy, K., Mathis, D., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/378356 · Cited by 218
Arroyo, J., Miller, C., Catalan, J., Myers, G. A., Ratterree, M. S., Trent, D. W., & Monath, T. P. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12497-12507.2004 · Cited by 213
Re-emergence of Chikungunya virus in India
Ravi, V (2006) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.25175 · Cited by 208
Pau, M. G., Ophorst, C., Koldijk, M. H., Schouten, G., Mehtali, M., & Uytdehaag, F. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00508-9 · Cited by 195
Chimeric alphavirus vaccine candidates for chikungunya
Wang, E., Volkova, E., Adams, A. P., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.054 · Cited by 191
Pepperell, C. S., Rau, N., Krajden, S., Kern, R. Z., Humar, A., Mederski, B., Simor, A. E., Low, D. E., McGeer, A., Mazzulli, T., et al. (2003) · Europe PMC (PubMed Central) · Cited by 175
Guirakhoo, F., Zhang, Z.-X., Chambers, T. J., Delagrave, S., Arroyo, J., Barrett, A. D. T., & Monath, T. P. (1999) · Virology · doi:10.1006/viro.1999.9695 · Cited by 171
Sutter, R. W., Kew, O. M., & Cochi, S. L. (2008) · Vaccines · doi:10.1016/b978-1-4160-3611-1.50030-1 · Cited by 167
Chikungunya Infection in Travelers
Hochedez, P., Jaureguiberry, S., Debruyne, M., Bossi, P., Hausfater, P., Brucker, G., Bricaire, F., & Caumes, E. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1210.060495 · Cited by 160
Monath, T. P. C., Caldwell, J. R., Mundt, W., Fusco, J., Johnson, C., Buller, M., Liu, J., Gardner, B., Downing, G., Blum, P. S., et al. (2004) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(04)00134-1 · Cited by 159
Self-citationNicolson, C., Major, D., Wood, J., & Robertson, J. S. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.08.054 · Cited by 158
First record of Aedes albopictus establishment in Italy.
Pozza, G. L. D., & Majori, G. (1992) · PubMed · Cited by 152
Katz, J. M., & Webster, R. G. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/160.2.191 · Cited by 148
Durbin, A. P., Whitehead, S. S., McArthur, J. H., Perreault, J. R., Blaney, J. E., Thumar, B., Murphy, B. R., & Karron, R. A. (2005) · The Journal of Infectious Diseases · doi:10.1086/427780 · Cited by 125
Spruth, M., Kistner, O., Savidis-Dacho, H., Hitter, E., Crowe, B. A., Gerenčer, M., Brühl, P., Grillberger, L., Reiter, M., Tauer, C., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.08.055 · Cited by 121
Self-citationBlaney, J. E., Sathe, N. S., Goddard, L. B., Hanson, C. T., Romero, T. A., Hanley, K. A., Murphy, B. R., & Whitehead, S. S. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.11.082 · Cited by 109
van Wezel, A. L., van Steenis, G., Hannik, C. A., & Cohen, H. (1978) · PubMed · Cited by 100
Dengue Vaccines Approach the Finish Line
Edelman, R. (2007) · Clinical Infectious Diseases · doi:10.1086/518148 · Cited by 98
Tauber, E., Kollaritsch, H., von Sonnenburg, F., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/590116 · Cited by 94
Poliovirus Vaccine–Inactivated
Vidor, E. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00047-x · Cited by 89
The New Pentavalent Rotavirus Vaccine Composed of Bovine (Strain WC3) -Human Rotavirus Reassortants
Clark, H. F., Offit, P. A., Plotkin, S. A., & Heaton, P. M. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000220283.58039.b6 · Cited by 83
Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine
Qin, E.-D., Shi, H., Tang, L., Wang, C., Chang, G., Ding, Z., Zhao, K., Wang, J., Chen, Z., Yu, M., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.06.038 · Cited by 75
Rhim, J. S., Schell, K. R., Creasy, B., et al. (1969) · Experimental Biology and Medicine · doi:10.3181/00379727-132-34285 · Cited by 75
Qu, D., Zheng, B., Yao, X. S., Guan, Y., Yuan, Z.-H., Zhong, N., Lu, L., Xie, J.-P., & Wen, Y. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.07.031 · Cited by 72
Hardy, C. T., Young, S. A., Webster, R. G., et al. (1995) · Virology · doi:10.1006/viro.1995.1405 · Cited by 66
Fifteen years of experience with Vero-produced enhanced potency inactivated poliovirus vaccine
Vidor, E. J., Meschievitz, C., & Plotkin, S. A. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199703000-00011 · Cited by 63
Dang‐Tan, T., Mahmud, S. M., Puntoni, R., & Franco, E. L. (2004) · Oncogene · doi:10.1038/sj.onc.1207877 · Cited by 49
Live Attenuated Human Rotavirus Vaccine, Rotarix™
Bernstein, D. I. (2006) · Seminars in Pediatric Infectious Diseases · doi:10.1053/j.spid.2006.08.006 · Cited by 35
Japanese encephalitis vaccine in travelers
Jelı́nek, T. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.5.689 · Cited by 34
Robertson, J. S., Nicolson, C., Major, D., Robertson, E. W., & Wood, J. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-10-2047 · Cited by 34
Abortive Infection of Vero Cells by an Influenza A Virus (FPV)
Lau, S. C., & Scholtissek, C. (1995) · Virology · doi:10.1006/viro.1995.1473 · Cited by 33
Absence of viral sequences in the WHO-Vero Cell Bank. A collaborative study.
Horaud, F. (1992) · PubMed · Cited by 26
Biodefense and special pathogen vaccines
Pittman, P. R., & Plotkin, S. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00044-6 · Cited by 5
Cited by
Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies
Cid, R., & Bolívar, J. (2021) · Biomolecules · doi:10.3390/biom11081072 · Cited by 176
Rourou, S., Ben Zakkour, M., & Kallel, H. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.05.092 · Cited by 53
Shen, X., Chen, X., Tabor, D. E., Liu, Y., Albarghouthi, M., Zhang, Y.-F., & Galinski, M. S. (2013) · Biologicals · doi:10.1016/j.biologicals.2012.12.001 · Cited by 15
Metadata
- Authors
- Barrett, P. N., Mundt, W., Kistner, O., & Howard, M. K.
- Venue
- Expert Review of Vaccines
- Publisher
- Informa UK Limited
- Published
- 2009-05
- Volume
- 8
- Issue
- 5
- Pages
- 607-618
- ISSN
- 1476-0584 (ISSN-L)
- 1744-8395
- OpenAlex
- W2092237558
- Cited by
- 281
- References
- 53
- FWCI
- 7.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.